11.07.2015 Views

For The Defense, October 2010 - DRI Today

For The Defense, October 2010 - DRI Today

For The Defense, October 2010 - DRI Today

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

D R U G A N D M E D I C A L D E V I C EStaying in the GameBy Kelly E. Jonesand Daniella D. DaCunzoE-Discoverywith aLive ProductIn cases involving activelymarketed products,counsel must not onlyreinforce litigationholds, but also keeptrack of changes andavoid disclosure of allthings privileged.Despite the vast number of prescription and over-thecounterdrugs involved in litigation today, only a smallpercentage of those lawsuits involve products that havebeen recalled or withdrawn from the market. A recalledor no longer marketed product allows counselto sequester all potential litigation discoverymaterials at one point in time andgive appropriately measured considerationto newly created documents. In contrast,preserving and collecting electronicallystored information (ESI) in litigation presentscounsel with special challenges whenthis information involves a “live” product,meaning a product currently on the market.A live or actively marketed product requirescounsel to “stay in the discovery game” bycontinually supplementing discovery productions,often with imminent deadlines,without hindering a company’s daily functions.This article will address some of thesteps that counsel should consider whenconducting discovery for “live” products.Makers of actively marketed pharmaceuticaland medical device products may facelitigation while still in the process of modifyinglabels or designing an actual productat issue. In those cases, regulatory counselmust address regulatory issues at thesame time as liability counsel reviews documentsfor discovery purposes. <strong>The</strong>se activities,together with a company’s ongoingmanufacturing efforts, generate numerousdocuments and ESI, creating an enormouschallenge. Counsel and a client must preserverelevant information and ensure thatthe collection process is as complete as reasonablypossible. To ensure faithful adherenceto the rules of ESI discovery, counselmust understand their duties and follow thesteps outlined below.Rules of the Game: Discovery UnderPension Committee and ZubulakeJudge Shira Scheindlin, author of the significante- discovery opinions in the Zubulakecases, has recently rearticulatedcounsel’s e- discovery duties in PensionComm. of the Univ. of Montreal PensionPlan v. Bank of Am. Sec., LLC, 685 F. Supp.2d 456 (S.D.N.Y. <strong>2010</strong>), holding that partiesmust “participate meaningfully andfairly” in the discovery process. Id. at 463.32 n <strong>For</strong> <strong>The</strong> <strong>Defense</strong> n <strong>October</strong> <strong>2010</strong>■ Kelly E. Jones and Daniella D. DaCunzo are associates of Harris Beach PLLC in New York City and aremembers of the firm’s e-info electronic information counseling and management team. <strong>The</strong>y both primarilylitigate and consult in cases involving pharmaceuticals and medical devices. Ms. Jones is currently theYoung Lawyers liaison to <strong>DRI</strong>’s Drug and Medical Device Committee and the chair of the Young LawyersMembership Subcommittee.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!